NIAID Banner Logo Image


1. 59710 DMID-LS-134; PUBMED-DMID-12/18/2006

Antiviral activity obtained from aqueous extracts of the Chilean soapbark tree (Quillaja saponaria Molina)

Roner, MR, Sprayberry, J, Spinks, M, and Dhanji, S

J Gen Virol 2007. 88(Pt 1): 275-85


2. 59711 DMID-LS-134; PUBMED-DMID-12/18/2006

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Yu, KL, Sin, N, Civiello, RL, Wang, XA, Combrink, KD, Gulgeze, HB, Venables, BL, Wright, JJ, Dalterio, RA, Zadjura, L, Marino, A, Dando, S, D'Arienzo, C, Kadow, KF, Cianci, CW, Li, Z, Clarke, J, Genovesi, EV, Medina, I, Lamb, L, Colonno, RJ, Yang, Z, Krystal, M, and Meanwell, NA

Bioorg Med Chem Lett 2006.


3. 59712 DMID-LS-134; PUBMED-DMID-12/18/2006

Dengue Virus RNA Polymerase NS5: A Potential Therapeutic Target?

Rawlinson, SM, Pryor, MJ, Wright, PJ, and Jans, DA

Curr Drug Targets 2006. 7(12): 1623-38


4. 59713 DMID-LS-134; PUBMED-DMID-12/18/2006

An Overall Picture of SARS Coronavirus (SARS-CoV) Genome-Encoded Major Proteins: Structures, Functions and Drug Development

Chen, S, Luo, H, Chen, L, Chen, J, Shen, J, Zhu, W, Chen, K, Shen, X, and Jiang, H

Curr Pharm Des 2006. 12(35): 4539-4553


5. 59714 DMID-LS-134; PUBMED-DMID-12/18/2006

SARS-CoV: A Scenario of Modern Drug Design

Huang, X

Curr Pharm Des 2006. 12(35): 4537-8


6. 59715 DMID-LS-134; EMBASE-DMID-12/18/2006

Enantioselective synthesis and antiviral activity of purine and pyrimidine cyclopentenyl C-nucleosides

Rao, Jagadeeshwar R, Schinazi, Raymond F, and Chu, Chung K

Bioorganic & Medicinal Chemistry 2007. 15(2): 839-846


7. 59716 DMID-LS-134; PUBMED-DMID-12/19/2006

Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase

Lai, L, Han, X, Chen, H, Wei, P, Huang, C, Liu, S, Fan, K, Zhou, L, Liu, Z, Pei, J, and Liu, Y

Curr Pharm Des 2006. 12(35): 4555-64


8. 59717 DMID-LS-134; EMBASE-DMID-12/18/2006

A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis

Puig-Basagoiti, Francesc, Tilgner, Mark, Bennett, Corey J, Zhou, Yangsheng, Munoz-Jordan, Jorge L, Garcia-Sastre, Adolfo, Bernard, Kristen A, and Shi, Pei-Yong

Virology 2006. In Press, Corrected Proof


9. 59718 DMID-LS-134; PUBMED-DMID-12/18/2006

The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA

Ye, Q, Krug, RM, and Tao, YJ

Nature 2006.


10. 59719 DMID-LS-134; PUBMED-DMID-12/19/2006

N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication

Lei, YC, Tian, YJ, Ding, HH, Wang, BJ, Yang, Y, Hao, YH, Zhao, XP, Lu, MJ, Gong, FL, and Yang, DL

World J Gastroenterol 2006. 12(46): 7488-96


11. 59720 DMID-LS-134; PUBMED-DMID-12/18/2006

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

Bai, F, Town, T, Pradhan, D, Cox, J, Ashish, Ledizet, M, Anderson, JF, Flavell, RA, Krueger, JK, Koski, RA, and Fikrig, E

J Virol 2006.


12. 59721 DMID-LS-134; PUBMED-DMID-12/18/2006

Synthesis and Antiviral Evaluation of Some Sugar Arylglycinoylhydrazones and Their Oxadiazoline Derivatives

Abdel-Aal, MT, El-Sayed, WA, and El-Ashry, ES

Arch Pharm (Weinheim) 2006. 339(12): 656-663


13. 59722 DMID-LS-134; EMBASE-DMID-12/18/2006

Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain

Lanford, Robert E, Guerra, Bernadette, and Lee, Helen

Virology 2006. 355(2): 192-202


14. 59723 DMID-LS-134; PUBMED-DMID-12/18/2006

Synthesis and Biological Evaluation of Some Pyrrolo[2,3-d]pyrimidines

Rashad, AE, Mohamed, MS, Zaki, ME, and Fatahala, SS

Arch Pharm (Weinheim) 2006. 339(12): 664-669


15. 59724 DMID-LS-134; PUBMED-DMID-12/19/2006

Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents

Ghosh, SK, Forman, LW, Akinsheye, I, Perrine, SP, and Faller, DV

Blood Cells Mol Dis 2006.


16. 59725 DMID-LS-134; PUBMED-DMID-12/19/2006

Anti-influenza virus agents: Synthesis and mode of action

Lagoja, IM and De Clercq, E

Med Res Rev 2006.


17. 59726 DMID-LS-134; PUBMED-DMID-12/18/2006

Inhibition of SARS-CoV Gene Expression by Adenovirus-Delivered Small Hairpin RNA

Zhang, X, Wu, K, Yue, X, Zhu, Y, and Wu, J

Intervirology 2006. 50(2): 63-70


18. 59727 DMID-LS-134; PUBMED-DMID-12/19/2006

Application of artificial zinc-finger proteins to inhibition of DNA replication of human papillomavirus

Mino, T, Mori, T, Matsumoto, N, Mineta, Y, Okamoto, T, Aoyama, Y, and Sera, T

Nucleic Acids Symp Ser (Oxf) 2006.(50): 313-4


19. 59728 DMID-LS-134; PUBMED-DMID-12/19/2006

Anti-SARS-CoV activity of nucleoside analogs having 6-chloropurine as a nucleobase

Ikejiri, M, Saijo, M, Morikawa, S, Fukushi, S, Mizutani, T, Kurane, I, and Maruyama, T

Nucleic Acids Symp Ser (Oxf) 2006.(50): 113-4


20. 59729 DMID-LS-134; WOS-DMID-12/18/2006

Use of Neuraminidase Inhibitors to Combat Pandemic Influenza

Democratis, J., Pareek, M., and Stephenson, I.

Journal of Antimicrobial Chemotherapy 2006. 58(5): 911-915


21. 59730 DMID-LS-134; PUBMED-DMID-12/18/2006

Efficacy of Delayed Treatment of ST-246 Given Orally Against Systemic Orthopoxvirus Infections in Mice

Quenelle, DC, Buller, RM, Parker, S, Keith, KA, Hruby, DE, Jordan, R, and Kern, ER

Antimicrob Agents Chemother 2006.


22. 59731 DMID-LS-134; PUBMED-DMID-12/18/2006

Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A

Tataridis, D, Fytas, G, Kolocouris, A, Fytas, C, Kolocouris, N, Foscolos, GB, Padalko, E, Neyts, J, and De, Clercq E

Bioorg Med Chem Lett 2006.


23. 59732 DMID-LS-134; WOS-DMID-12/18/2006

Conformational Maturation of the Nucleoprotein Synthesized in Influenza C Virus-Infected Cells

Sugawara, K. et al.

Virus Research 2006. 122(1-2): 45-52


24. 59733 DMID-LS-134; PUBMED-DMID-12/19/2006

Structural and mechanistic insights into hepatitis C viral translation initiation

Fraser, CS and Doudna, JA

Nat Rev Microbiol 2007. 5(1): 29-38


25. 59734 DMID-LS-134; WOS-DMID-12/18/2006

Strategies for Developing Vaccines Against H5n1 Influenza a Viruses

Horimoto, T. and Kawaoka, Y.

Trends in Molecular Medicine 2006. 12(11): 506-514


26. 59735 DMID-LS-134; PUBMED-DMID-12/19/2006

Kinetics, inhibition and oligomerization of Epstein-Barr virus protease

Buisson, M, Rivail, L, Hernandez, JF, Jamin, M, Martinez, J, Ruigrok, RW, and Burmeister, WP

FEBS Lett 2006. 580(28-29): 6570-8


27. 59736 DMID-LS-134; WOS-DMID-12/18/2006

Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel

Shi, D. et al.

Journal of Pharmacology and Experimental Therapeutics 2006. 319(3): 1477-1484


28. 59737 DMID-LS-134; EMBASE-DMID-12/18/2006

The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1

Biswas, Subhajit, Jennens, Lyn, and Field, Hugh J

Antiviral Research 2006. In Press, Corrected Proof


29. 59738 DMID-LS-134; EMBASE-DMID-12/18/2006

Synthesis of the 5-phosphono-pent-2-en-1-yl nucleosides: A new class of antiviral acyclic nucleoside phosphonates

Choo, Hyunah, Beadle, James R, Chong, Youhoon, Trahan, Julissa, and Hostetler, Karl Y

Bioorganic & Medicinal Chemistry 2006. In Press, Corrected Proof


30. 59739 DMID-LS-134; EMBASE-DMID-12/18/2006

Synthesis, in vitro and in silico assessment of organometallic Rhenium(I) and Technetium(I) thymidine complexes

Stichelberger, M, Desbouis, D, Spiwok, V, Scapozza, L, Schubiger, PA, and Schibli, R

Journal of Organometallic Chemistry 2006. In Press, Corrected Proof


31. 59740 DMID-LS-134; EMBASE-DMID-12/18/2006

Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylates

Zhao, Chunshen, Zhao, Yanfang, Chai, Huifang, and Gong, Ping

Bioorganic & Medicinal Chemistry 2006. 14(8): 2552-2558


32. 59741 DMID-LS-134; EMBASE-DMID-12/18/2006

Combination Therapy with Cyclophosphamide and the Oncolytic Herpes Virus Mutant rRp450, Expressing a Cyclophosphamide Prodrug, Is Clinically Safe by Intratumoral, Intravenous, and Intracerebral Administration in an HSV-1 Susceptible Mouse Model

Currier, Mark A, Mahller, Yonatan Y, Stroup, Greg, Kambara, Hirokazu, Chiocca, EA, and Cripe, Timothy P

Molecular Therapy 2006. 13(Supplement 1): S253


33. 59742 DMID-LS-134; EMBASE-DMID-12/18/2006

Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III

Phillpotts, RJ

Virus Research 2006. 120(1-2): 107-112


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2023